Brief: SSY Group Obtained Approval For Drug Production And Registration For Deferasirox From NMPA China
10/12/2024 06:44
Dec 10 (Reuters) - SSY Group Ltd 2005.HK :
* OBTAINED APPROVAL FOR DRUG PRODUCTION AND REGISTRATION FOR
DEFERASIROX DISPERSIBLE TABLETS (125MG) FROM NMPA CHINA
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth